🔎 Trials Near Me

Akèy › Karsinòm selil skuamèz tèt ak kou › Kalifòni › San Francisco

Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan San Francisco, CA

10 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote San Francisco (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Ap rekriteFaz 2/3
  • Site #0130, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06788990

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Ap rekriteFaz 3
  • University of California San Francisco, San Francisco
Laj 60 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT04892173

Intratumoral N17350 in Advanced Solid Tumors

Ap rekriteFaz 1/2
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07339176

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Ap rekriteFaz 2/3
  • UCSF Medical Center-Mission Bay, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04333537

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • UCSF Medical Center at Mission Bay, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT06993844

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

Ap rekriteFaz 1/2
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06097468

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Ap rekriteFaz 1
  • University of California San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT06778863

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

Ap rekriteEtid obsèvasyon
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Dec 12, 2025 · NCT06606028

A Study of NX-1607 in Adults With Advanced Malignancies

Ap rekriteFaz 1
  • University of California, San Francisco, San Francisco
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil

Lòt etid nan San Francisco

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.